“Hong Kong BIO-MED Innovation Association” to seize opportunities for biotech industry development, be committed to establish an innovative and international biomedical technology platform in Hong Kong
To actively introduce excellent bio-pharmaceutical innovation technology projects and industries from overseas and provide assistance in various aspects, including formulating industrialization and commercial development plans, fund raising and listing, corporate governance and auditing, R&D technology, patent protection, policies and regulations, clinical trial design and planning, etc. to enter the Mainland China market;
Cross-strait Bio-Med Innotech Alliance
The Alliance is co-founded by HK-Bio Med Innotech Association, China Pharmaceutical Innovation and Research Development Association (PhIRDA), Institute for Biotechnology and Medicine Industry and International Association of Quality Research in Chinese Medicine;
The goal is to create a bio-pharmaceutical innovation and cooperation platform, which will establish a platform for joint scientific and technological innovation talent in HK, China, Taiwan and Macau, promoting regulatory convergence of international standards, accelerating the sharing of the four pharmaceutical markets, and achieving the effective deployment of capital markets. It will aim to develop itself into a collaborative channel for Asian and all overseas Chinese in global biomedical industry.